Histone modifications underlie monocyte dysregulation in patients with systemic sclerosis, underlining the treatment potential of epigenetic targeting

  1. Van Der Kroef, M.
  2. Castellucci, M.
  3. Mokry, M.
  4. Cossu, M.
  5. Garonzi, M.
  6. Bossini-Castillo, L.M.
  7. Chouri, E.
  8. Wichers, C.G.K.
  9. Beretta, L.
  10. Trombetta, E.
  11. Silva-Cardoso, S.
  12. Vazirpanah, N.
  13. Carvalheiro, T.
  14. Angiolilli, C.
  15. Bekker, C.P.J.
  16. Affandi, A.J.
  17. Reedquist, K.A.
  18. Bonte-Mineur, F.
  19. Zirkzee, E.J.M.
  20. Bazzoni, F.
  21. Radstake, T.R.D.J.
  22. Rossato, M.
Aldizkaria:
Annals of the Rheumatic Diseases

ISSN: 1468-2060 0003-4967

Argitalpen urtea: 2019

Alea: 78

Zenbakia: 4

Orrialdeak: 529-538

Mota: Artikulua

DOI: 10.1136/ANNRHEUMDIS-2018-214295 GOOGLE SCHOLAR